Bluejay Diagnostics (BJDX) Change in Account Payables (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Change in Account Payables of $6033.0 for Q1 2026, down 88.64% sequentially from $53093.0 in Q4 2025, and down 98.39% YoY from $374402.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Change in Account Payables (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Change in Account Payables for 7 years, with the latest figure at $6033.0 in Q1 2026.
- Quarterly Change in Account Payables fell 98.39% year-over-year to $6033.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$299236.0 (down 220.81% YoY) and the FY2025 annual result came in at $69133.0, up 119.96% from the prior year.
- Change in Account Payables retreated to $6033.0 in Q1 2026 per BJDX's latest filing, from $53093.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $448199.0 in Q3 2023 and troughed at -$520728.0 in Q2 2022.
- A 5-year average of -$31809.1 and a median of -$54392.0 in 2023 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 630.41% in 2022, down 789.36% in 2022.
- Over 5 years, Change in Account Payables stood at $97670.0 in 2022, then slumped by 360.44% to -$254369.0 in 2023, then soared by 32.57% to -$171528.0 in 2024, then jumped by 130.95% to $53093.0 in 2025, then slumped by 88.64% to $6033.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $6033.0, $53093.0, and $52345.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | 453,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 453,801.00 |
| Jun 30, 2026 | 453,801.00 |
| Mar 31, 2026 | 6,033.00 |
| Mar 31, 2026 | 6,033.00 |
| Dec 31, 2025 | 53,093.00 |
| Dec 31, 2025 | 53,093.00 |
| Sep 30, 2025 | 52,345.00 |
| Sep 30, 2025 | 52,345.00 |
| Jun 30, 2025 | -410,707.00 |
| Jun 30, 2025 | -410,707.00 |
| Mar 31, 2025 | 374,402.00 |
| Mar 31, 2025 | 374,402.00 |
| Dec 31, 2024 | -171,528.00 |
| Dec 31, 2024 | -171,528.00 |
| Sep 30, 2024 | -173,406.00 |
| Sep 30, 2024 | -173,406.00 |
| Jun 30, 2024 | 218,231.00 |
| Jun 30, 2024 | 218,231.00 |
| Mar 31, 2024 | -219,649.00 |
| Mar 31, 2024 | -219,649.00 |